Inve US ▾
ULUL

Unilever (UL) Q2 FY25 earnings call: guidance and Q&A

Earnings call· Jun 2025 (Q2 FY25)· Consumer Staples· Jul 31, 2025

Source: earnings call transcript

Executive summary

Unilever Q2 FY25 — Strong Developed Market Performance & Emerging Market Improvement

Unilever delivered a solid first half, driven by sustained strong performance in developed markets and clear signs of improvement in emerging markets, particularly Asia. The company is actively transforming its portfolio through strategic bolt-on acquisitions in Beauty & Personal Care and planned disposals, alongside the ongoing demerger of its Ice Cream business. Management expressed confidence in accelerating growth in the second half, underpinned by a commitment to multi-year volume growth and consistent gross margin expansion, while maintaining competitive brand investment levels.

Highlights

5
  • Underlying sales growth for H1 was 3.4%, with a good balance of volume and price, and volumes improving sequentially.

  • Developed markets continued strong performance, with North America USG of 5.4% (volumes up 3.7%) and Europe USG of 3.4% (volumes up 2.8%) for the half.

  • Emerging markets showed improving trends, with Asia Pacific Africa up 3.5% in H1 and accelerating to over 5% growth in Q2.

  • The productivity program is significantly ahead of expectations, now targeting EUR 650 million in cumulative savings by year-end, EUR 100 million above prior guidance.

  • The Ice Cream business began operating as a stand-alone entity on July 1, ahead of its mid-November demerger.

Concerns

5
  • Latin America experienced a 4.6% volume decline in H1, primarily due to pricing actions to offset currency movements and subdued markets.

  • Turnover for H1 was down 3.2% year-on-year, significantly impacted by a negative currency effect of 4%.

  • Free cash flow for H1 2025 was EUR 1.1 billion, a decrease from EUR 2.2 billion in the prior year, due to lower operating profit, Ice Cream separation costs, and higher working capital.

  • A weak quarter in Hair Care in the U.S. was noted, specifically due to an unsuccessful attempt to reposition pricing for TRESemmé shampoos.

  • The U.S. market saw continued softness in prestige beauty brands like Dermalogica and Paula's Choice.

Guidance & targets

CategoryTargetConfidence
Underlying Sales Growth
3% to 5%
high materiality
High
Underlying Operating Margin
at least 18.5%
high materiality
High
Free Cash Flow Conversion
around 100%
medium materiality
High
Effective Tax Rate
around 26%
low materiality
High
Net Debt-to-EBITDA Ratio (Unilever ex-Ice Cream)
approximately 2x
high materiality
High
Net Debt-to-EBITDA Ratio (Magnum Ice Cream Company)
around 2.4x
high materiality
High
Multi-year Volume Growth
at least 2%
high materiality
High
Gross Margin Expansion
consistently expand
high materiality
High
Underlying Sales Growth (Multi-year)
mid-single-digit
high materiality
High
Margin Improvement (Multi-year)
modest
high materiality
High
Hard Currency EPS Growth
positive
high materiality
Medium

Segment performance

SegmentRevenueYoYQoQMargin
Developed Markets
Continued strong performance for four consecutive quarters, with growth above 4%.
Volume growth: 3.4%Price growth: 0.9%Percentage of group turnover: 44%
—4.3%——
North America
Reflects ongoing portfolio transformation and strong performances from Wellbeing brands and Personal Care.
Volume growth: 3.7%
—5.4%——
Europe
Broad-based growth across markets, winning share, driven by Home Care and Ice Cream innovations.
Volume growth: 2.8%
—3.4%——
Asia Pacific Africa
Growth strengthened in Q2, reflecting step-up in performance across key markets. Expected further acceleration in H2.
Volume growth: 1.9%Price growth: 1.6%Percentage of group turnover: 43%
—3.5%accelerated to over 5% growth in Q2—
India
Performed well with continued share gains in a gradually improving market, led by premium portfolio in Beauty & Wellbeing and Personal Care.
Volume growth: largely driven by volume in Q2
—5% USG in Q2improved sequentially—
Indonesia
Seeing improvements to run rates due to significant interventions and innovation plans. Expected further acceleration in H2.
—declined around 5%low single-digit decline in Q2—
China
Seeing improvements to run rates due to significant interventions and innovation plans. Expected further acceleration in H2, despite soft overall market.
——low single-digit decline in Q2—
Latin America
Pricing actions to offset currency movements weighed on volumes. Market growth remains subdued. Expected recovery later in the year.
Volume decline: 4.6%Percentage of group turnover: 13%
—0.5%——
Beauty & Wellbeing
Sustained strong momentum in Wellbeing business led growth. Core Skin Care delivered low single-digit growth. Hair Care and Prestige Beauty were flat. Volumes impacted by corrective actions in Indonesia and China.
Volume growth: 1.7%Price growth: 2%2-year volume CAGR: 3.2%
—3.7%—19.4% (down 60 bps)
Personal Care
Good first half, despite softening volumes in Q2 due to subdued macro conditions in Latin America and pricing actions. Dove grew high single digit. Deodorants and Skin Cleansing grew low single digit. Oral Care delivered mid-single-digit growth.
Volume growth: 1.4%Price growth: 3.3%2-year volume CAGR: 2.3%
—4.8%—22.1% (down 90 bps)
Home Care
Q2 growth driven by sequential improvement in Asia and momentum of premium innovations in Europe, partially offset by decline in Latin America. Fabric Cleaning declined low single digit, impacted by Brazil.
Volume growth: 1.1%Price growth: 0.2%
—1.3%1.8% in Q215.5% (down 80 bps)
Foods
Growth improved in Q2 led by Hellmann's and Knorr. Unilever Food Solutions was flat. Margin improvement reflects disciplined pricing, mix management, and productivity.
Volume growth: 0.3%Price growth: 1.9%
—2.2%improved in Q223.3% (improved 100 bps)
Ice Cream
Supported by actions to enhance innovations, pricing, and operations. Both In-home and Out-of-home segments grew mid-single digits. Double-digit growth in Magnum led performance.
Volume growth: 3.8%Price growth: 2%
—5.9%—declined 40 bps

Deals & partnerships

Wild refillable deodorant brand

Acquisition completed in April, strengthening the Personal Care portfolio in the natural space.

Dr. Squatch high-performing male grooming brand

Agreement signed in June to acquire this brand, filling gaps in the super premium male grooming segment, particularly in North America.

Minimalist premium actives-led beauty brand

Acquisition completed in April, supporting the evolution of the Beauty & Wellbeing portfolio in India.

Elida Beauty non-strategic asset

Sale completed in June 2024 as part of portfolio pruning.

Unilever Russia business operations

Exit completed in October 2024 as part of portfolio changes.

Water purification business non-strategic business

Exit completed in October 2024 as part of portfolio changes.

The Vegetarian Butcher non-strategic asset

Sale announced in March, reflecting focus on businesses with potential to be scaled.

Capital programs

Productivity Program underway

Benefit:EUR 650 million cumulative savings

Program is significantly ahead of expectations, with cumulative savings target raised by EUR 100 million from prior guidance.

Risks & headwinds

Macro and Currency Environment Uncertainty Full Year 2025

Currency impact on full year turnover between 5% and 6%; around 20 basis points on underlying operating margin.

Mitigation:Remaining agile and adjusting plans if necessary; continued focus on gross margin expansion and productivity.

Inflationary Pressures H1 2025 (ongoing)

Experienced from both commodities and currency in H1 2025, most notably in Ice Cream, Personal Care, and Latin America.

Mitigation:Implemented calibrated price increases across the portfolio; enhanced focus on productivity and buying efficiencies; good covers with physical and financial instruments.

Latin America Market Subdued Conditions H1 2025 (expected to improve H2)

Market volume growth moved from 7% growth in H1 2024 to negative in Q2 2025; 4.6% volume decline in H1 2025 for Unilever.

Mitigation:Restoring strategic pricing relativity (e.g., Laundry Brazil); continued innovation in brands; focus on protecting leadership positions.

Competitive Pressures in Laundry Brazil Q2 2025

Lost competitiveness and some share loss due to pricing actions in powder format.

Mitigation:Corrected pricing in powders; rolling out successful European Wonder Wash mix in Q3; expecting quick return to competitiveness.

Weakness in U.S. Hair Care H1 2025

Unsuccessful attempt to reposition pricing for TRESemmé shampoos led to volume decline.

Mitigation:Pricing has been corrected to ensure competitiveness; conscious decision to focus portfolio behind Power Brands (Dove, TRESemmé, Nexxus, SheaMoisture).

Softness in U.S. Prestige Market H1 2025

Weighed on performance of brands like Dermalogica and Paula's Choice.

Mitigation:Continued investment in premium, high-growth spaces and digital commerce footprint.

Challenging China Market H1 2025 (expected to return to growth H2)

Overall market remains soft, out-of-home eating showed some improvement in Q2 but still soft.

Mitigation:Fundamental work on go-to-market strategies; good confidence in run rates; expecting return to growth in H2.

Free Cash Flow Decline H1 2025

H1 2025 FCF was EUR 1.1 billion, compared to EUR 2.2 billion in prior year.

Mitigation:Confident in full year FCF delivery of around 100% conversion; inventory increases for supply chain resilience will be reversed in H2.

What to watch in Q3 FY25

Ice Cream Demerger Completion

mid-November
Current operating as stand-alone since July 1
Target completed

Why it matters

Marks a significant portfolio simplification and strategic shift for Unilever, impacting its financial profile and strategic focus.

The demerger of the Ice Cream will take place in mid-November.

Find out whether UL delivers this. Inve re-checks your case every morning.

Q&A highlights

Will the ex-Ice Cream portfolio accelerate in H2, potentially reaching 4-6% growth, and what are the drivers for volume acceleration in Personal Care and Beauty & Wellbeing?

Management is confident in achieving over 2% volume growth for the remaining company in H2, citing improving market volumes, strengthening brand power (UBS scores), outperformance in developed markets, accelerating India growth, sustained competitive BMI levels, and a strong innovation pipeline. They expect significant contributions from Indonesia and China.

“We run the business with the intention of delivering volume growth about 2% for our remaining company, and we are very confident that we will achieve that in the second half.”

asked by Celine Pannuti · answered by Fernando Fernandez

3 min read 6 chapters

Detailed narrative

Ice Cream Demerger Progress and Strategic Stake

The demerger of the Ice Cream business is on track for mid-November 2025, with the entity operating as a stand-alone business since July 1. A Capital Markets Day for The Magnum Ice Cream Company is scheduled for September 9 in London to present its strategy.

Unilever intends to retain a stake of just below 20% in the demerged company for up to five years, signaling confidence in its potential. Proceeds from the eventual sale of this stake will cover separation costs, tax liabilities, and reduce net debt.

Post-demerger, Unilever expects a net debt-to-EBITDA ratio of approximately 2x, while The Magnum Ice Cream Company is projected to have a solid investment-grade profile of around 2.4x.

Portfolio Transformation and Strategic M&A

Unilever is actively shifting its portfolio towards higher-growth segments, particularly Beauty & Wellbeing and Personal Care, and strengthening its presence in key markets like the U.S. and India. This involves bolt-on acquisitions such as Wild (refillable deodorant), Dr. Squatch (male grooming), and Minimalist (actives-led beauty).

Concurrently, the company is executing a disposal plan of EUR 1.5 billion to EUR 2 billion, including non-strategic assets like The Vegetarian Butcher, Elida Beauty, Unilever Russia, and its water purification business, to accelerate portfolio rotation and focus on core strengths.

Developed Markets Outperformance

Developed markets continue to be a strong growth engine, delivering four consecutive quarters of underlying sales growth above 4%. North America's 5.4% USG, driven by 3.7% volume, reflects successful portfolio transformation and strong performance in Wellbeing brands (Liquid IV, Nutrafol) and Personal Care.

Europe also maintained robust growth at 3.4% USG, with 2.8% volume, fueled by premium innovations like Wonder Wash and Cif Infinite Clean. This outperformance is attributed to focused investment in Power Brands and strong retailer partnerships.

Emerging Markets Turnaround and Regional Dynamics

Emerging markets are showing clear signs of improvement, led by Asia Pacific Africa, which accelerated to over 5% growth in Q2. India demonstrated strong performance with 5% USG in Q2, driven by volume and share gains. Interventions in Indonesia and China are yielding improvements, with expectations for further acceleration in H2.

However, Latin America faced challenges, with a 4.6% volume decline in H1 due to macroeconomic slowdowns, currency depreciation, and pricing actions, though management expects some improvement later in the year.

Operational Excellence and Cost Discipline

Unilever is prioritizing operational excellence, with a focus on consistent gross margin expansion to fund competitive brand marketing investment (BMI at 15.5% of turnover). The productivity program is significantly ahead of schedule, now targeting EUR 650 million in cumulative savings by year-end.

Overheads improved by 10 basis points due to productivity gains and tighter cost control, even while incurring costs for the Ice Cream separation. The company emphasizes a new culture of cost discipline across product and overhead levels.

Vaseline: A Case Study in 'Desire at Scale'

The brand Vaseline serves as a prime example of Unilever's 'desire at scale' strategy, demonstrating an 11% compounded annual growth rate over the last four years and over 10% volume growth in 2024 and H1 2025. This transformation involved breakthrough science (e.g., Gluta-Hya), elevated brand aesthetics, and modern persuasion models, including social-first campaigns and influencer collaborations.

The success of Vaseline, particularly in its biggest markets like the U.S. and India, is being replicated across other Power Brands to drive consistent high-quality growth.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.